Detalhe da pesquisa
1.
Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial.
Pharmacoecon Open
; 8(1): 19-30, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606866
2.
A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.
Value Health
; 16(8): 1133-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24326166
3.
Hospital Resource Utilization and Costs in Patients with Heart Failure in France.
Pharmacoecon Open
; 7(6): 927-940, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713172
4.
Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France.
J Scleroderma Relat Disord
; 7(1): 49-56, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35386942
5.
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.
Front Med (Lausanne)
; 8: 699532, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552943
6.
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study.
Neuropsychiatr Dis Treat
; 14: 239-249, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29386897
7.
Pattern and predictors of sick leave among users of antidepressants: a Danish retrospective register-based cohort study.
J Affect Disord
; 151(3): 959-66, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24035488